Order Article Reprints

Damjanovska S, Alao H, Zebrowski E, Kowal C, Kostadinova L, Davitkov P, Falck-Ytter Y, Shive CL, Cartwright M, Richardson B, et al. During HCV DAA Therapy Plasma Mip1B, IP10, and miRNA Profile Are Distinctly Associated with Subsequent Diagnosis of Hepatocellular Carcinoma: A Pilot Study. Biology. 2022; 11(9):1262. https://doi.org/10.3390/biology11091262

Damjanovska, Sofi, Hawwa Alao, Elizabeth Zebrowski, Corinne Kowal, Lenche Kostadinova, Perica Davitkov, Yngve Falck-Ytter, Carey L. Shive, Michael Cartwright, Brian Richardson, and et al. 2022. "During HCV DAA Therapy Plasma Mip1B, IP10, and miRNA Profile Are Distinctly Associated with Subsequent Diagnosis of Hepatocellular Carcinoma: A Pilot Study" Biology 11, no. 9: 1262. https://doi.org/10.3390/biology11091262

Damjanovska, S., Alao, H., Zebrowski, E., Kowal, C., Kostadinova, L., Davitkov, P., Falck-Ytter, Y., Shive, C. L., Cartwright, M., Richardson, B., Wald, D., Cameron, M., Valadkhan, S., & Anthony, D. D. (2022). During HCV DAA Therapy Plasma Mip1B, IP10, and miRNA Profile Are Distinctly Associated with Subsequent Diagnosis of Hepatocellular Carcinoma: A Pilot Study. Biology, 11(9), 1262. https://doi.org/10.3390/biology11091262